Neutropenia: all 405 studies
Page 3 of 5. Open to participants first (59), then studies with results posted, then the rest; newest registration first within each.
- A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent FeverCompletedNCT03511820
- Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)Status unknownNCT03498248Not applicable
- Efficacy of Oral Supplementation With Magnesium to Reduce Febrile NeutropeniaStatus unknownNCT03449693Phase 2
- An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)CompletedNCT03433560
- PET/CT and Bacterial/Fungal PCR in High Risk Febrile NeutropeniaCompletedNCT03429387Not applicable
- Severe PID With Lymphoproliferation and NeutropeniaCompletedNCT03427593Not applicable
- Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.Status unknownNCT03404752Phase 3
- iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic PatientsStatus unknownNCT03364257
- Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematologyTerminatedNCT03342365
- Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and NeutropeniaCompletedNCT03333005Phase 1
- Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced NeutropeniaActive, not recruitingNCT03294577Phase 3
- Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric PatientsCompletedNCT03262584
- Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer PatientsCompletedNCT03251768Phase 2
- Fusion Protein rHSA/GCSFclinical Study on Breast Cancer PatientsCompletedNCT03246009Phase 1
- Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCTCompletedNCT03233776Phase 2
- Antibiotics Management of Septic Neutropenic Patients in the Intensive Care UnitCompletedNCT03217721
- Community-Led Action Research in Oncology: Improving Symptom ManagementCompletedNCT03208816Not applicable
- To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical CancerStatus unknownNCT03206684Phase 4
- Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile NeutropeniaTerminatedNCT03182465Not applicable
- Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast CancerCompletedNCT03104595Phase 1/2
- Shared Health Information System for Febrile NeutropeniaCompletedNCT03087227Not applicable
- Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN StudyTerminatedNCT03003273Phase 3
- PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent NeutropeniaStatus unknownNCT02996617Phase 4
- Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer PatientsStatus unknownNCT02967341Phase 4
- Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic AssayCompletedNCT02912117
- Early Antibiotic Discontinuation in FUOCompletedNCT02906254
- Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid LeukemiaCompletedNCT02856204
- A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile NeutropeniaCompletedNCT02816164Phase 4
- Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile NeutropeniaCompletedNCT02816112Phase 4
- Profiling Neutrophil Counts in Patients on ChemotherapyStatus unknownNCT02806557
- PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent NeutropeniaCompletedNCT02805205Phase 4
- Pegteograstim in Children With Solid TumorsStatus unknownNCT02787876Phase 2
- Study on Efficacy and Safety of CBLB612 for Neutropenia ProphylaxisCompletedNCT02778763Phase 2
- A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)CompletedNCT02766647Phase 1
- A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)CompletedNCT02766634Phase 1
- The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced NeutropeniaStatus unknownNCT02761460Phase 3
- Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring ProphylaxisCompletedNCT02755857Phase 2
- Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast CancerStatus unknownNCT02725606Phase 1
- The Oral Cavity as a Source of Febrile NeutropeniaCompletedNCT02702583
- Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy VolunteersCompletedNCT02700360Phase 1
- Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced NeutropeniaCompletedNCT02692742Phase 2
- Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)TerminatedNCT02685111Phase 2
- Vitamin Supplementation in NSCLC Patients on Pemetrexed Based ChemotherapyCompletedNCT02679443Not applicable
- Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy SubjectsCompletedNCT02643901Phase 1
- A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy ParticipantsCompletedNCT02629289Phase 1
- Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mgCompletedNCT02621905Phase 4
- Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim FormulationsCompletedNCT02589301Phase 1
- Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer PatientsStatus unknownNCT02544685Phase 2
- Granulocyte Transfusions in Hematological Patients With Febrile NeutropeniaCompletedNCT02544230
- ANF-Rho in the Treatment of Chronic NeutropeniaWithdrawnNCT02533362Phase 1/2
- Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy VolunteersCompletedNCT02532712Phase 1
- A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic ChemotherapyCompletedNCT02522234Phase 1/2
- A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.CompletedNCT02521441Phase 2
- A Safety and PK Study of EC-18 in Healthy SubjectsCompletedNCT02496143Phase 1
- Multicenter Prospective Registry Study of Diffuse Large B Cell LymphomaStatus unknownNCT02474550
- Efficacy and Safety Study With MYL-1401H and NeulastaCompletedNCT02467868Phase 3
- Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion ProteinCompletedNCT02465801Phase 2
- Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile NeutropeniaStatus unknownNCT02463747Phase 4
- A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)CompletedNCT02428114
- Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%CompletedNCT02414581Phase 3
- Cohort of Peripheral T Cell LymphomaStatus unknownNCT02364466
- SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced NeutropeniaCompletedNCT02324231Not applicable
- Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid LeukemiaCompletedNCT02282215Phase 2
- The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic LeukemiaCompletedNCT02272673
- Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive LymphomaStatus unknownNCT02238873Phase 3
- Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile NeutropeniaCompletedNCT02213783Phase 4
- Hematopoietic Stem Cell Transplant for High Risk HemoglobinopathiesTerminatedNCT02179359Not applicable
- Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic TumorsCompletedNCT02156388Phase 1
- Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUOCompletedNCT02149329Phase 4
- A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.Status unknownNCT02135887
- A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving ChemotherapyCompletedNCT02119715Phase 2
- A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced NeutropeniaCompletedNCT02044276Phase 3
- Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving ChemotherapyCompletedNCT02005458Phase 2
- Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood DyscrasiaCompletedNCT01974401Phase 2
- Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaCompletedNCT01923545Phase 2
- Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat NeutropeniaCompletedNCT01919710Phase 1
- Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced NeutropeniaStatus unknownNCT01918241Phase 2
- Bone Marrow Transplant With Abatacept for Non-Malignant DiseasesCompletedNCT01917708Phase 1
- Hepatosplenic CANdidiasis : PETscan and Immune Response AnalysisCompletedNCT01916057Not applicable
- Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe NeutropeniaStatus unknownNCT01849237Phase 1/2
- Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional ChemotherapyCompletedNCT01799421
- Effect of Body Mass on Filgrastim PharmacokineticsCompletedNCT01719432
- Piperacillin/Tazobactam for Empirical Therapy of Febrile NeutropeniaCompletedNCT01714570Not applicable
- Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell TransplantationStatus unknownNCT01714557Not applicable
- A Study of Empirical Antifungal Therapy With ItraconazoleCompletedNCT01706562
- Registry of Febrile Neutropenia and Invasive Fungal InfectionsStatus unknownNCT01684189
- Pediatric FN Definition 2012 BernCompletedNCT01683370
- Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian CancerStatus unknownNCT01680575
- Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaCompletedNCT01674855Phase 3
- The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological MalignanciesCompletedNCT01669005
- Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell TransplantWithdrawnNCT01660347Not applicable
- Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile NeutropeniaStatus unknownNCT01658956Phase 2
- Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate CancerCompletedNCT01649635Phase 4
- Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy PatientsStatus unknownNCT01637493Phase 1
- Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid LeukemiaCompletedNCT01629082Phase 1
- A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving ChemotherapyCompletedNCT01611051Phase 3
- Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and NeutropeniaCompletedNCT01581333Phase 4
- Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic AgentsCompletedNCT01574235
- Prevention of Neutropenia After Using G-CSF With TAC ChemotherapyStatus unknownNCT01571518Phase 4
- A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving ChemotherapyStatus unknownNCT01560195Phase 3